Publications

SCHOOL of nature: ligand-independent immunomodulatory peptides

The SCHOOL of nature: IV. Learning from viruses

The SCHOOL of nature: III. From mechanistic understanding to novel therapies

The SCHOOL of nature: II. Protein order, disorder and oligomericity in transmembrane signaling

The SCHOOL of nature: I. Transmembrane signaling

Novel mechanistic insights into viral modulation of immune receptor signaling

Immune cell signaling: a novel mechanistic model reveals new therapeutic targets

Multichain immune recognition receptor signaling: different players, same game?

SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale

Triggering receptor expressed on myeloid cells-1 (TREM-1) contributes to Bordetella pertussis inflammatory pathology

Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes

Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation

Targeting Tumor-Associated Macrophages to Radiosensitize Glioblastoma in a Mouse Model

Novel TREM-1 Inhibitors Attenuate Tumor Growth and Prolong Survival in Experimental Pancreatic Cancer

A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock

Blockade of TREM-1 prevents vitreoretinal neovascularization in mice with oxygen-induced retinopathy

Inhibition of TREM-2 markedly suppresses joint inflammation and damage in experimental arthritis

Rationally designed ligand-independent peptide inhibitors of TREM-1 ameliorate collagen-induced arthritis

SARS Coronavirus Fusion Peptide-Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice